Super Religare Labs raises $66M
Super Religare Laboratories (SRL), a unit of Fortis Healthcare, has announced its third private equity (PE) deal in the past 14 months. This time, NYLIM Jacob Ballas India Fund, a mid-market private equity firm with more than $600...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.